IUPAC NAME-4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile
MOLECULAR FORMULA-C17H11N5
MOLAR MASS-285.303 g/mol
Letrozole is approved by the United States Food and Drug Administration for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women
SWAPNROOP DRUGS & PHARMACEUTICALS is a high tech enterprise which engaged in Loan Licensing Manufacturing of Pharmaceutical Products and Pharmaceutical Raw Materials. We are working under the guideline of GMP regulation also certification of ISO9000/HACCP,offering hundreds of chemical products for global market based on our three national producing bases. winning a high reputation of global customer with our good credit efficiency work, good quality and after service.
View more >>
Basic Information
Business Type: Manufacturer,Trading Company,Distributor/Wholesaler
Product/Service (We Buy): 11 - 50 People
Ownership Type: Individual (Sole proprietorship)
Registered Capital: US$501 Thousand - US$1 Million
Year Established: 2000
Number of Employees: 11 - 50 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 4
Number of R&D Staff: 98
Number of QC Staff: 11 - 20 People
Total Annual Sales Volume: US$5 Million - US$10 Million
India
China 
